An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
NCT00089557 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
This study is an open-label, multicenter, extension study for subjects who completed NeurogesX Study C111 and received treatment with NGX-4010 (Capsaicin Patch) within 12 weeks (up to +7days) before entry into Study C114
Conditions
- Herpes Zoster
- Neuralgia
- Pain
- HIV Infections
- Peripheral Nervous System Diseases
- Diabetic Neuropathies
- Diabetes Mellitus
- Polyneuropathies
Interventions
- DRUG
-
Capsaicin Dermal Patch
Sponsors & Collaborators
-
NeurogesX
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy
NCT00064623 ·Status: COMPLETED ·Phase: PHASE3
-
NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00061776 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of NGX-4010 on ENFD and Sensory Function
NCT00254449 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)
NCT00916942 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00115310 ·Status: COMPLETED ·Phase: PHASE3
-
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00300222 ·Status: COMPLETED ·Phase: PHASE3
-
Study of MRgFUS Exablate Treatment Following the Neuropathic Pain
NCT04649554 ·Status: TERMINATED ·Phase: NA
-
Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy
NCT00061152 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy
NCT00110500 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
NCT01086150 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain
NCT01207596 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain
NCT00414349 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain
NCT00414466 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
NCT04688671 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain
NCT01035281 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain
NCT02228928 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
NCT04476108 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
NCT00576277 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Exablate Model 4000 Type 1.0/1.1 Following the Treatment of Neuropathic Pain
NCT05802511 ·Status: COMPLETED ·Phase: NA
-
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
NCT00904202 ·Status: COMPLETED ·Phase: PHASE4
-
Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy
NCT01125215 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia
NCT00845923 ·Status: COMPLETED ·Phase: PHASE2
-
Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain
NCT02441660 ·Status: COMPLETED ·Phase: NA